Product Review

Product News: 03 2014

This issue features new products such as Bensal HP for the treatment of inflammation and irritation associated with many common forms of dermatitis, including certain eczematoid conditions; an authorized generic form of Cloderm Cream (clocortolone pivalate 0.1%), which provides patients and physicians with the same clinical benefits of the Cloderm Cream brand with the potential to increase access to this treatment; Effaclar Dermatological Acne System for over-the-counter treatment of acne; Glytone by Ducray hair care solutions for hair loss and scaly scalp; and Luzu (luliconazole cream 1%) approval by the US Food and Drug Administration for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis.


 

Recommended Reading

New HIPAA Requirements
MDedge Dermatology
Myofibroma
MDedge Dermatology
What Does ICD-10 Mean for Dermatologists?
MDedge Dermatology
Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
MDedge Dermatology
Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 5: A Guide on the Management of Rosacea
MDedge Dermatology
Cutaneous Squamous Cell Carcinoma With Perineural Invasion: A Case Report and Review of the Literature
MDedge Dermatology
Localized Diffuse Melanosis Associated With Melanoma Successfully Treated With Imiquimod Cream 5%: A Case Report and Review of the Literature
MDedge Dermatology
Nicotinamide and Reflections on Alan Shalita and George Hambrick Jr
MDedge Dermatology
Basal Cell Carcinoma: Analysis of Factors Associated With Incomplete Excision at a Referral Hospital in Southern Spain
MDedge Dermatology
Microcystic Adnexal Carcinoma: Review of a Potential Diagnostic Pitfall and Management
MDedge Dermatology